Johnson & Johnson recalls infant gas relief drops
Johnson & Johnson-Merck Consumer Pharmaceuticals company is voluntarily recalling approximately 12,000 units of Infants' Mylicon Gas Relief Dye-Free Drops (simethicone-antigas), according to the FDA.
Johnson & Johnson-Merck Consumer Pharmaceuticals company is voluntarily recalling approximately 12,000 units of Infants' Mylicon Gas Relief Dye-Free Drops (simethicone-antigas), according to the FDA.
The non-staining drops were sold in 1 oz. plastic bottles and were distributed after October 5, 2008. nationwide. The consumer recall is meant as a precaution after determining that some bottles could include metal fragments that were generated during the manufacturing process.
The FDA states that if any medical events resulting from use of the recalled products were to occur, most would be expected to be temporary and resolve without medical treatment. However, consumers who purchased two specific lots of this product are being advised to stop using the product and contact the manufacturer for further instructions.
The full FDA recall announcement, as well as contact information for consumers, can be found on the FDA Web site.
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.
